Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yuxia Sui"'
Autor:
ZhenChao Zhang, JingWei Huang, MengHui Li, YuXia Sui, Shuai Wang, LianRui Liu, LiXin Xu, RuoFeng Yan, XiaoKai Song, XiangRui Li
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115411 (2014)
In the present study, the microneme 5 gene of Eimeria acervulina (E. acervulina) (EaMIC5) was cloned and characterized. Specific primers for the rapid amplification of cDNA ends (RACE) were designed based on the expressed sequence tag (EST, GenBank A
Externí odkaz:
https://doaj.org/article/f732880b8b904dd78f84462427c23f9b
Autor:
Xuewen Wang, Dafen Xu, Bing Chen, Dandan Huang, Zhijun Li, Yuxia Sui, Fei Lin, Hong Yao, Huang Yuan Li, Xinhua Lin
Publikováno v:
Oxidative Medicine and Cellular Longevity. 2022:1-16
Our previous studies have shown that delicaflavone (DLL), a biocomponent extracted from Selaginella doederleinii Hieron, has antitumor activity. However, the role of DLL in the antitumor immune response is unknown. In this study, we tested the potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c122a9966800f2ea9207f7cae0ab3dc
https://doi.org/10.1155/2022/8619275
https://doi.org/10.1155/2022/8619275
Publikováno v:
Analytical Sciences. 37:1349-1353
In recent years, more and more research is being conducted on microRNAs and their involvement in the regulation of autophagy phagocytosis which is closely related to tumor growth. MicroRNA-21 is a kind of small RNA that can regulate gene expression a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd8523c14e3f280c492c37cbcad80dbf
https://doi.org/10.2116/analsci.20p404
https://doi.org/10.2116/analsci.20p404
Publikováno v:
OncoTargets and Therapy. 13:10315-10322
Background The incidence and mortality of lung cancer continue to increase around the world; in 2018, new lung cancer cases accounted for 11.6% of all cancer cases, and lung cancer deaths accounted for 18.4% of cancer deaths. Cisplatin (DDP) is a fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c4798d02ada9d5dd61456036c11d8e6
https://doi.org/10.2147/ott.s255586
https://doi.org/10.2147/ott.s255586
Publikováno v:
Pharmacogenomics. 21:43-53
Aim: To assess the cost–effectiveness of CYP2D6*10 genetic testing for the management of Chinese women with hormone receptor-positive (HR+) breast cancer treated with selective estrogen receptor modulator. Methods: A Markov model was developed to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::174ebd51e4307302704c4a7b48b11859
https://doi.org/10.2217/pgs-2019-0073
https://doi.org/10.2217/pgs-2019-0073
Publikováno v:
OncoTargets and therapy
Background The incidence and mortality of lung cancer continue to increase around the world; in 2018, new lung cancer cases accounted for 11.6% of all cancer cases, and lung cancer deaths accounted for 18.4% of cancer deaths. Cisplatin (DDP) is a fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e024f137f34d14f1d00453ace8bc46ac
https://pubmed.ncbi.nlm.nih.gov/33116611
https://pubmed.ncbi.nlm.nih.gov/33116611
Publikováno v:
Diagnostic Pathology. 1/13/2017, Vol. 12, p1-4. 4p.
Autor:
Yuxia Sui, Jiaqin Cai, Chenxia Xu, Na Li, Bin Zheng, Xiaoxia Wei, Jie Zhuang, Hong Sun, Guifeng Zhang
Publikováno v:
Pharmacogenomics. 20(4)
Aim: To assess the cost–effectiveness of UGT1A1*6/*28 genotyping compared with no genotyping or no dose adjustment before irinotecan administration in China. Materials & methods: A decision tree model was developed to evaluate costs and health outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60065c848fadec94e2a14d09c6fb0443
https://pubmed.ncbi.nlm.nih.gov/30628534
https://pubmed.ncbi.nlm.nih.gov/30628534
Autor:
Wensong Yao, Zhen Lin, Peiying Shi, Bing Chen, Gang Wang, Jianyong Huang, Yuxia Sui, Qicai Liu, Shaoguang Li, Xinhua Lin, Hong Yao
Publikováno v:
Biochemical Pharmacology. 171:113680
Colorectal cancer (CRC) is one of the most common malignant tumors worldwide and tends to have drug resistance. Delicaflavone (DLF), a novel anticancer agent of biflavonoid from Selaginella doederleinii Hieron, showed strong anti-CRC activities, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2980227490b0561efab931099ccc780b
https://doi.org/10.1016/j.bcp.2019.113680
https://doi.org/10.1016/j.bcp.2019.113680
Autor:
Wensong Yao, Zhen Lin, Gang Wang, Shaoguang Li, Bing Chen, Yuxia Sui, Jianyong Huang, Qicai Liu, Peiying Shi, Xinhua Lin, Hong Yao
Publikováno v:
Phytomedicine. 62:152973
Background Cervical cancer (CCa) represents the fourth most common cause of cancer-related death in women worldwide. CCa therapy is still a major clinical challenge worldwide. Finding and developing new anti-CCa chemotherapeutic drugs is a very signi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3287a50f201ee066b3f09bfac7e8ab99
https://doi.org/10.1016/j.phymed.2019.152973
https://doi.org/10.1016/j.phymed.2019.152973